| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 3, Issue 4 225-232, Copyright © 1992 by American Association of Cancer Research
ARTICLES |
ZS Zheng, R Polakowska, A Johnson and LA Goldsmith
Columbia University College of Physicians and Surgeons, Department of Dermatology, New York, New York 10032.
Retinoic acid (RA) and epidermal growth factor (EGF) regulate growth and differentiation of epithelial cells. RA has both direct and indirect effects on gene expression. Direct effects result from modulation of the transcriptional activity of genes, which contain RA response elements (RARE) recognized by trans-acting nuclear RA receptors (RARs). A second indirect mechanism for the modulatory effects of RA is by the induction or repression of growth factors and growth factor receptors. There is evidence for functional interactions between RA and the EGF receptor (EGFR). RA enhances the proliferative response of cultured keratinocytes to EGF, increases the number of EGFRs on the surface of some cells, and induces EGFR promoter activity in most cells. In contrast, immunoprecipitation, Northern blot, and nuclear run-on analysis described in this paper show that RA suppresses EGFR synthesis at the transcriptional level in human epidermoid carcinoma ME180 cells. Deletion analysis of EGFR gene promoter mutants linked to the chloramphenicol acetyltransferase gene revealed the existence of a region of the promoter, -771 to -384, which is responsive to RA. Gel retardation data indicated that a cell-type nuclear protein which binds to this novel element is suppressed by RA in a dose-dependent manner. This decrease coincides with a decreased steady-state level of RAR-gamma mRNA. These data strongly suggest that the EGFR promoter is regulated by RAR-gamma, which itself is under the control of RA. Other cell-specific trans-acting factors may be involved in this regulation.
This article has been cited by other articles:
![]() |
M. Lango, A. L. Wentzel, J. I. Song, S. Xi, D. E. Johnson, W. W. Lamph, L. Miller, and J. R. Grandis Responsiveness to the Retinoic Acid Receptor-selective Retinoid LGD1550 Correlates with Abrogation of Transforming Growth Factor {alpha}/Epidermal Growth Factor Receptor Autocrine Signaling in Head and Neck Squamous Carcinoma Cells Clin. Cancer Res., September 15, 2003; 9(11): 4205 - 4213. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Chinni and F. H. Sarkar Akt Inactivation Is a Key Event in Indole-3-carbinol-induced Apoptosis in PC-3 Cells Clin. Cancer Res., April 1, 2002; 8(4): 1228 - 1236. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nishi, M. Senoo, K. H. Nishi, B. Murphy, T. Rikiyama, Y. Matsumura, S. Habu, and A. C. Johnson p53 Homologue p63 Represses Epidermal Growth Factor Receptor Expression J. Biol. Chem., November 2, 2001; 276(45): 41717 - 41724. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Potter Morphostats: A Missing Concept in Cancer Biology Cancer Epidemiol. Biomarkers Prev., March 1, 2001; 10(3): 161 - 170. [Abstract] [Full Text] |
||||
![]() |
X.-W. Liu, Y. Katagiri, H. Jiang, L.-J. Gong, L.-Y. Guo, M. Shibutani, A. C. Johnson, and G. Guroff Cloning and Characterization of the Promoter Region of the Rat Epidermal Growth Factor Receptor Gene and Its Transcriptional Regulation by Nerve Growth Factor in PC12 Cells J. Biol. Chem., March 15, 2000; 275(10): 7280 - 7288. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kaiser, F. H. Brembeck, B. Nicke, B. Wiedenmann, E.-O. Riecken, and S. Rosewicz All-trans-Retinoic Acid-mediated Growth Inhibition Involves Inhibition of Human Kinesin-related Protein HsEg5 J. Biol. Chem., July 2, 1999; 274(27): 18925 - 18931. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Chen, D. Lavelle, J. DeSimone, S. Uddin, L. C. Platanias, and M. Hankewych Growth Inhibition of a Human Myeloma Cell Line by All-trans Retinoic Acid Is Not Mediated Through Downregulation of Interleukin-6 Receptors but Through Upregulation of p21WAF1 Blood, July 1, 1999; 94(1): 251 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Reed, H. Yamazaki, J. D. Kaufman, Y. Rubinstein, B. Murphy, and A. C. Johnson Molecular Cloning and Characterization of a Transcription Regulator with Homology to GC-binding Factor J. Biol. Chem., August 21, 1998; 273(34): 21594 - 21602. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D.E. Liaudet-Coopman and A. Wellstein Regulation of Gene Expression of a Binding Protein for Fibroblast Growth Factors by Retinoic Acid J. Biol. Chem., August 30, 1996; 271(35): 21303 - 21308. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Desai, M. Michalak, N. K. Singh, and R. M. Niles Inhibition of Retinoic Acid Receptor Function and Retinoic Acid-regulated Gene Expression in Mouse Melanoma Cells by Calreticulin. A POTENTIAL PATHWAY FOR CYCLIC AMP REGULATION OF RETINOID ACTION J. Biol. Chem., June 21, 1996; 271(25): 15153 - 15159. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |